Bristol-Myers Squibb Co (LIM:BMY) Other Operating Expense : $7,345 Mil (TTM As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Bristol-Myers Squibb Co Other Operating Expense?

Bristol-Myers Squibb Co's Other Operating Expense for the three months ended in Mar. 2025 was $830 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was $7,345 Mil.

Bristol-Myers Squibb Co's quarterly Other Operating Expense declined from Sep. 2024 ($2,406 Mil) to Dec. 2024 ($1,693 Mil) and declined from Dec. 2024 ($1,693 Mil) to Mar. 2025 ($830 Mil).

Bristol-Myers Squibb Co's annual Other Operating Expense declined from Dec. 2022 ($9,595 Mil) to Dec. 2023 ($9,047 Mil) and declined from Dec. 2023 ($9,047 Mil) to Dec. 2024 ($8,872 Mil).

Bristol-Myers Squibb Co Other Operating Expense Historical Data

The historical data trend for Bristol-Myers Squibb Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Other Operating Expense Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

9,764.00

10,023.00

9,595.00

9,047.00

8,872.00

Bristol-Myers Squibb Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															2,357.00	2,416.00	2,406.00	1,693.00	830.00

Bristol-Myers Squibb Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $7,345 Mil.

Bristol-Myers Squibb Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (LIM:BMY) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BRM:Germany BRM:Germany BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.